Gout Flare: Clinical Trials

3 trials for Gout Flare, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1
Phase 31Recruiting 1

Follow Gout Flare: new trials by email Literature Review of Gout Flare trials Research Report on Gout Flare

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
ABP-745 Dose A, ABP-745 Dose B, Colchicine - Acute Gouty Arthritis, Gout Flare
Phase 2CompletedAtom Therapeutics Co., Ltd4792025-08-262026-10-28
Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare
Genakumab for injection, Colchicine - Acute Gout, Gout Flare
Phase 2CompletedChangchun GeneScience Pharmaceutical Co., Ltd.1062023-07-212024-11-08
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Dapansutrile, Placebo Tablet - Acute Gout Flare, Gout Attack
Phase 2 / Phase 3RecruitingOlatec Therapeutics, Inc.3002023-01-062026-03-11

Narrower conditions

Gout (2)  ·  Arthralgia (1)  ·  Arthritis (1)  ·  Arthritis, Gouty (1)  ·  Hyperuricemia (1)  ·  Inflammation (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Crystal Arthropathies (2)  ·  Genetic Diseases, Inborn (2)  ·  Joint Diseases (2)  ·  Metabolic Diseases (2)  ·  Metabolism, Inborn Errors (2)  ·  Musculoskeletal Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Purine-Pyrimidine Metabolism, Inborn Errors (2)  ·  Rheumatic Diseases (2)  ·  Arthritis (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Colchicine (2)  ·  Injections (1)  ·  dapansutrile (1)

Sponsors

Atom Therapeutics Co., Ltd (1)  ·  Changchun GeneScience Pharmaceutical Co., Ltd. (1)  ·  Olatec Therapeutics, Inc. (1)

Countries

China (2)  ·  United States (2)  ·  Australia (1)  ·  France (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Spain (1)

Top investigators

Hejian Zou (1)

Results publications

PMID 40833487